Antiemetic Medication Guideline

Introduction to Antiemetic Medications

Promethazine has a concerning side effect profile, including severe anticholinergic effects, sedation, and serious safety concerns, with a FDA black box warning for injectable forms, and is generally considered less safe than trimethobenzamide 1

Promethazine has an onset of action within 5 minutes of IV administration, with a duration of 4-6 hours and a half-life of 9-16 hours, and its mechanisms include H1-receptor antagonist, dopamine receptor blockade, and anticholinergic effects 1

Promethazine causes strong anticholinergic effects, including dry mouth, urinary retention, blurred vision, and cognitive impairment, as well as sedation, drowsiness, hypotension, dizziness, and epigastric discomfort, and is associated with respiratory depression, especially when combined with opioids, and extrapyramidal symptoms and dystonic reactions 1

For patients with respiratory conditions, trimethobenzamide is preferred due to a lower risk of respiratory depression, and if promethazine must be used, it should be administered slowly (25 mg/min) to minimize hypotension risk 1
Elderly patients should start with lower doses (6.25 mg) due to increased sensitivity to anticholinergic effects, higher risk of sedation and confusion, altered drug metabolism and elimination, and increased risk of extrapyramidal side effects, as suggested by the American Geriatrics Society 1

The American Geriatrics Society explicitly cautions against the use of promethazine in elderly patients due to its high anticholinergic burden and fall risk, and recommends against using first-generation antihistamines like promethazine in older adults due to significant risks of anticholinergic effects, sedation, confusion, and other adverse events that outweigh potential benefits 2, 3, 1
Trimethobenzamide may be preferred for patients with cardiovascular disease due to its less hypotensive effect, and ondansetron 4 mg can be used as an alternative to promethazine, with fewer anticholinergic effects 4, 1
The National Comprehensive Cancer Network recommends prochlorperazine 10 mg PO every 6 hours or haloperidol 0.5-1 mg PO every 6-8 hours as alternatives to promethazine when contraindicated or not tolerated, and diphenhydramine 25-50 mg can be used as an alternative H1-receptor antagonist to promethazine 4, 1

The recommended dose of promethazine for adults is 12.5 to 25 mg every 4-6 hours, with a maximum of 25-50 mg in 24 hours, according to the Gastroenterology guidelines, and should be taken with food to reduce gastrointestinal irritation and ensure adequate hydration 5, 1, 6
Promethazine is contraindicated in children under 2 years of age due to the risk of fatal respiratory depression, seizures, and potential association with sudden infant death syndrome, and the American Academy of Pediatrics recommends weight-based dosing (0.5 mg/kg/dose) for promethazine in children over 2 years 5, 7

Concomitant use of other CNS depressants (especially opioids) increases the risk of adverse events in elderly patients taking promethazine, and pre-existing conditions like prostatic hypertrophy, glaucoma, cognitive impairment, cardiovascular disease, and respiratory conditions should be considered when managing cough in elderly patients 2, 3
If promethazine use is absolutely necessary, starting with the lowest possible dose (6.25mg) and monitoring closely for mental status changes, urinary retention, orthostatic hypotension, and respiratory depression is recommended, and using standard adult dosing in elderly patients significantly increases adverse effect risk, as warned by the Centers for Disease Control and Prevention 2, 3, 1

Non-pharmacological approaches such as adequate hydration, humidification, and honey (if not diabetic) can be used for cough management in elderly patients, and addressing the underlying cause of cough, such as using ipratropium bromide for chronic bronchitis or targeted therapy for specific conditions like COPD, is preferred 8
Safer pharmacological alternatives like peripheral cough suppressants (e.g. levodropropizine), ondansetron, and short-term use of dextromethorphan (with caution) can be considered for elderly patients requiring cough management 8